LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,518
تعداد مشاهده مقاله45,416,091
تعداد دریافت فایل اصل مقاله11,291,759
Jafari, Fatemeh, Mohseni Heidari, Sepideh, Shojaie, Layla, Vali, Mohebat, Jahani, Fatemeh, Mirzad, Seyed-Mostaffa, Nikbakht, Hossein-Ali, Hassanipour Azgomi, Soheil, Ghelichi- Ghojogh, Mousa, Ghaem, Haleh. (1402). Evaluation of the Results of Services Provided in Breast Cancer Counseling and Screening Clinics in Babol, 2012-2017. سامانه مدیریت نشریات علمی, 11(2), 308-316. doi: 10.30476/jhsss.2022.93107.1417
Fatemeh Jafari; Sepideh Mohseni Heidari; Layla Shojaie; Mohebat Vali; Fatemeh Jahani; Seyed-Mostaffa Mirzad; Hossein-Ali Nikbakht; Soheil Hassanipour Azgomi; Mousa Ghelichi- Ghojogh; Haleh Ghaem. "Evaluation of the Results of Services Provided in Breast Cancer Counseling and Screening Clinics in Babol, 2012-2017". سامانه مدیریت نشریات علمی, 11, 2, 1402, 308-316. doi: 10.30476/jhsss.2022.93107.1417
Jafari, Fatemeh, Mohseni Heidari, Sepideh, Shojaie, Layla, Vali, Mohebat, Jahani, Fatemeh, Mirzad, Seyed-Mostaffa, Nikbakht, Hossein-Ali, Hassanipour Azgomi, Soheil, Ghelichi- Ghojogh, Mousa, Ghaem, Haleh. (1402). 'Evaluation of the Results of Services Provided in Breast Cancer Counseling and Screening Clinics in Babol, 2012-2017', سامانه مدیریت نشریات علمی, 11(2), pp. 308-316. doi: 10.30476/jhsss.2022.93107.1417
Jafari, Fatemeh, Mohseni Heidari, Sepideh, Shojaie, Layla, Vali, Mohebat, Jahani, Fatemeh, Mirzad, Seyed-Mostaffa, Nikbakht, Hossein-Ali, Hassanipour Azgomi, Soheil, Ghelichi- Ghojogh, Mousa, Ghaem, Haleh. Evaluation of the Results of Services Provided in Breast Cancer Counseling and Screening Clinics in Babol, 2012-2017. سامانه مدیریت نشریات علمی, 1402; 11(2): 308-316. doi: 10.30476/jhsss.2022.93107.1417

Evaluation of the Results of Services Provided in Breast Cancer Counseling and Screening Clinics in Babol, 2012-2017

Journal of Health Sciences & Surveillance System
دوره 11، شماره 2، تیر 2023، صفحه 308-316    اصل مقاله (818.05 K)
نوع مقاله: Original Article
شناسه دیجیتال (DOI): 10.30476/jhsss.2022.93107.1417
نویسندگان
Fatemeh Jafari1؛ Sepideh Mohseni Heidari2؛ Layla Shojaie3؛ Mohebat Vali1؛ Fatemeh Jahani4؛ Seyed-Mostaffa Mirzad4؛ Hossein-Ali Nikbakht2؛ Soheil Hassanipour Azgomi5؛ Mousa Ghelichi- Ghojogh6؛ Haleh Ghaem* 7
1Student Research Committee,Shiraz University of Medical Sciences, Shiraz, Iran
2Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
3Division of GI/Liver, Department of Medicine, Keck school of Medicine, University of Southern California, Los Angeles, CA, USA
4Department of Health, Babol University of Medical Sciences, Babol, Iran
5Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran
6Neonatal and Children’s Health Research Center ResearchCenter, Golestan University of Medical Science, Gorgan, Iran
7Non-Communicable Diseases Research Center, Department of Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
Background: Successful treatment of breast cancer (BC) depends on its early detection, which has a significant role in reducing its mortality. The purpose of this study was to evaluate the services provided and the results in women referred to Babol Health Center Breast Cancer Screening Clinic.
Methods: This cross-sectional study was performed on 1421 individuals. Data were collected using a questionnaire, including demographic information, health history, and screening questions. Initial examinations were performed by midwives at the centers, and suspected or family history cases were referred to counseling centers and then to a physician for mammography. All follow-up was recorded by an expert in the center.
Results: The mean age of the subjects was 46.19±8.84 years, and that at first delivery was 21.08±4.38; 93 (6.5%) of them had a history of infertility and 253 (17.8%) had a family history of BC. Of those who did a clinical examination, mammography and ultrasound, 580 (40.9%), 171 (12%), and 441 (31.1%) had BIRADS above two, respectively, and 12 of those who performed biopsy had a positive mass result. Among the other variables studied, history of benign tumor (OR=2.86, P<0.001) and changes in breast skin (OR=2.96, P=0.021) and change in the breast size (OR=2.92, P. value=0.020). ) was observed in predicting effective mammography. In the random forest chart, the history of benign tumors showed 20.34% of mammographic predictions. Breast self-examination with 12.06% and then hormonal drugs with 10.45% were in the second and third ranks.
Conclusion: Using two methods of clinical examination and mammography will identify most people in stage 2 who have a good prognosis. Given the proper functioning of the center, it is suggested that more extensive screening should be done to reduce the prevalence and costs of treatment.
کلیدواژه‌ها
Breast neoplasms؛ Mass screening؛ Mammography؛ Breast self-examination
مراجع
  1. Ghoncheh M, Mohammadian-Hafshejani A, Salehiniya H. Incidence and mortality of breast cancer and their relationship to development in Asia. Asian Pac J Cancer Prev. 2015;16(14):6081-7. doi: 10.7314/apjcp.2015.16.14.6081. PMID: 26320499.
  2. Badrian M, Ahmadi P, Amani M, Motamedi N. Prevalence of risk factors for breast cancer in 20 to 69 years old women. Iran J Breast Dis. 2014;7(2):67-75. doi: 20.1001.1.17359406.1393.7.2.7.7.
  3. Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer (Dove Med Press). 2019;11:151-64. doi: 10.2147/BCTT.S176070. PMID: 31040712; PMCID: PMC6462164.
  4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. doi: 10.3322/caac.21492 . PMID: 30207593.
  5. Golbasi Z, Çetin R, Kalkan S, Durmus T. The knowledge and behaviors of female university students about breast cancer and breast self-examination. Eur J Breast Health. 2010;6(2):69-73. .
  6. Tabrizi FM, Vahdati S, Khanahmadi S, Barjasteh S. Determinants of Breast Cancer Screening by Mammography in Women Referred to Health Centers of Urmia, Iran. Asian Pac J Cancer Prev. 2018;19(4):997-1003. doi: 10.22034/APJCP.2018.19.4.997. PMID: 29693968; PMCID: PMC6031808.
  7. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90. DOI: 10.3322/caac.20107 . PMID: 21296855.
  8. Bouya S, Balouchi A, Ahmadidarehsima S, Badakhsh M. Knowledge and source of information about early detection techniques of breast cancer among women in Iran: a systematic review. J Cancer Prev. 2018;23(1):51-60. doi: 10.15430/JCP.2018.23.1.51. PMID: 29629349; PMCID: PMC5886495.
  9. Rezaianzadeh A, Azgomi SH, Mokhtari AM, Maghsoudi A, Nazarzadeh M, Dehghani SL, et al. The incidence of breast cancer in Iran: a systematic review and meta-analysis. J Anal Oncol. 2016;5(4):139-45. doi: 6000/1927-7229.2016.05.04.2.
  10. Beacham AO, Carpenter JS, Andrykowski MA. Impact of benign breast biopsy upon breast self-examination. Prev Med. 2004;38(6):723-31. doi: 10.1016/j.ypmed.2004.01.006. PMID: 15193892.
  11. Makanjuola O, Amoo P, Ajibade B, Makinde O. Breast cancer: knowledge and practice of breast self examination among women in rural community of Ondo State, Nigeria. IOSR J Pharm Biol Sci. 2013;8(1):32-7. doi:10.9790/3008-0813237.
  12. Bello T, Olugbenga-Bello A, Oguntola A, Adeoti M, Ojemakinde O. Knowledge and practice of breast cancer screening among female nurses and lay women in Osogbo, Nigeria. West Afr J Med. 2011;30(4):296-300. PMID: 22669837.
  13. Romeiro Lopes TC, Franca Gravena AA, Demitto MDO, Brischiliari SCR, Borghesan DHP, Dell Agnolo CM, et al. Mammographic screening of women attending a reference service center in Southern Brazil. Asian Pac J Cancer Prev. 2016;17(3):1385-91. doi: 10.7314/apjcp.2016.17.3.1385. PMID: 27039777.
  14. Mirmoammadi A, Parsa P, Khodakarami B, Roshanaei G. Effect of consultation on adherence to clinical breast examination and mammography in Iranian Women: A randomized control trial. Asian Pac J Cancer Prev. 2018;19(12):3443. doi: 10.31557/APJCP.2018.19.12.3443. PMID: 30583667; PMCID: PMC6428530.
  15. Rezaianzadeh A, Jalali M, Maghsoudi A, Mokhtari AM, Azgomi SH, Dehghani SL. The overall 5-year survival rate of breast cancer among Iranian women: a systematic review and meta-analysis of published studies. Breast Dis. 2017;37(2):63-8. doi: 10.3233/BD-160244. PMID: 28655117.
  16. Godfrey K, Agatha T, Nankumbi J. Breast cancer knowledge and breast self-examination practices among female university students in Kampala, Uganda: a descriptive study. Oman Med J. 2016;31(2):129-34. doi: 10.5001/omj.2016.25. PMID: 27168924; PMCID: PMC4861385.
  17. Griva F, Anagnostopoulos F, Gourounti K, Kolokotroni P, Koutrouli N. Mammography screening within the context of the theory of planned behavior: The role of personality traits and personal factors. Int J Psychol Stud. 2013;5(3):98-107. doi: 0.5539/ijps.v5n3p98.
  18. Bahrami M, Taymoori P, Bahrami A, Farazi E, Farhadifar F. The Prevalence of breast and Cervical Cancer screening and related factors in woman who refereeing to health center of Sanandaj city in 2014. J Adv Med Biomed Res. 2015;16(50):1-12.
  19. Yusof A, Chia YC, Hasni YM. Awareness and prevalence of mammography screening and its predictors—a cross sectional study in a primary care clinic in Malaysia. Asian Pac J Cancer Prev. 2014;15(19):8095-9. doi: 10.7314/apjcp.2014.15.19.8095. PMID: 25338990.
  20. Akhtari-Zavare M, Juni MH, Said SM, Ismail IZ. Beliefs and behavior of Malaysia undergraduate female students in a public university toward breast self-examination practice. Asian Pac J Cancer Prev. 2013;14(1):57-61. doi: 10.7314/apjcp.2013.14.1.57. PMID: 23534796.
  21. Koc G, Gulen-Savas H, Ergol S, Yildirim-Cetinkaya M, Aydin N. Female university students' knowledge and practice of breast self-examination in Turkey. Niger J Clin Pract. 2019;22(3):410-5. doi: 10.4103/njcp.njcp_341_18. PMID: 30837432.
  22. Provencher L, Hogue J, Desbiens C, Poirier B, Poirier E, Boudreau D, et al. Is clinical breast examination important for breast cancer detection? Curr Oncol. 2016;23(4):e332-e9. doi: 10.3747/co.23.2881. PMID: 27536182; PMCID: PMC4974039. 
  23. Nojomi M, Namiranian N, Myers RE, Razavi-Ratki S-K, Alborzi F. Factors associated with breast cancer screening decision stage among women in Tehran, Iran. Int J Prev Med. 2014;5(2):196-202. PMID: 24627747; PMCID: PMC3950743.
  24. Branigan GL, Soto M, Neumayer L, Rodgers K, Brinton RD. Association between hormone-modulating breast cancer therapies and incidence of neurodegenerative outcomes for women with breast cancer. JAMA Netw Open. 2020;3(3):e201541-e. doi: 10.1001/jamanetworkopen.2020.1541. PMID: 32207833; PMCID: PMC7093781.
  25. Mahvi DA, Liu R, Grinstaff MW, Colson YL, Raut CP. Local cancer recurrence: the realities, challenges, and opportunities for new therapies. CA Cancer J Clin. 2018;68(6):488-505. doi: 10.3322/caac.21498 .PMID: 30328620; PMCID: PMC6239861.
  26. Narod SA. Personalised medicine and population health: breast and ovarian cancer. Hum Genet. 2018;137(10):769-78. doi: 10.1007/s00439-018-1944-6. PMID: 30328515.
  27. Cain EH, Saha A, Harowicz MR, Marks JR, Marcom PK, Mazurowski MA. Multivariate machine learning models for prediction of pathologic response to neoadjuvaant therapy in breast cancer using MRI features: a study using an independent validation set. Breast Cancer Res Treat. 2019;173(2):455-63. doi: 10.1007/s10549-018-4990-9. PMID: 30328048; PMCID: PMC6483397.
  28. Autier P, Boniol M, Gavin A, Vatten LJ. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ. 2011;343(d4411):1-10. doi: .1136/bmj.d4411 . PMID: 21798968; PMCID: PMC3145837.
  29. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784-92. doi: 10.056/NEJMoa050518. PMID: 16251534. .
  30. Kalager M, Zelen M, Langmark F, Adami H-O. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med. 2010;363(13):1203-10. doi: 10.056/NEJMoa1000727 . PMID: 20860502.
  31. Autier P, Héry C, Haukka J, Boniol M, Byrnes G. Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening. J Clin Oncol. 2009;27(35):5919-23. doi: 10.1200/JCO.2009.22.7041. PMID: 19884547.
  32. Jørgensen KJ, Zahl P-H, Gøtzsche PC. Breast cancer mortality in organised mammography screening in Denmark: comparative study. BMJ. 2010;340(c1241):1-6. doi: 10.1136/bmj.c241. PMID: 20332505; PMCID: PMC2844939.
  33. Takkar N, Kochhar S, Garg P, Pandey A, Dalal UR, Handa U. Screening methods (clinical breast examination and mammography) to detect breast cancer in women aged 40–49 years. J Midlife Health. 2017;8(1):2-10. doi: .4103/jmh.JMH_26_16. PMID: 28458473; PMCID: PMC5367219.
  34. Berg WA, Zhang Z, Lehrer D, Jong RA, Pisano ED, Barr RG, et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 2012;307(13):1394-404. doi: 10.001/jama.2012.388. PMID: 22474203; PMCID: PMC3891886.
آمار
تعداد مشاهده مقاله: 334
تعداد دریافت فایل اصل مقاله: 174


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب